C
Corsano Health develops and manufactures the CE-MDR and FDA-cleared CardioWatch 287 system for continuous, multi-parameter vital sign monitoring in hospital and remote settings. This medical-grade wearable provides real-time physiological data and raw sensor streams to support clinical workflows and predictive analytics. The platform accelerates biomedical research by offering researchers unrestricted access to high-resolution data for biomarker development and digital therapy validation.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Corsano Health develops and manufactures the CE-MDR and FDA-cleared CardioWatch 287 system for continuous, multi-parameter vital sign monitoring in hospital and remote settings. This medical-grade wearable provides real-time physiological data and raw sensor streams to support clinical workflows and predictive analytics. The platform accelerates biomedical research by offering researchers unrestricted access to high-resolution data for biomarker development and digital therapy validation.